...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment
【24h】

Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment

机译:对碳酸酐酶靶向初级芳烃酰胺的1,2,4-氧代唑外周继续探索:发现脑结合HCA IX同种型亚甲醛抑制剂的发现,可选择性地杀死缺氧环境中的癌细胞

获取原文
获取原文并翻译 | 示例
           

摘要

An expanded set of diversely substituted 1,2,4-oxadiazole-containing primary aromatic sulfonamides was synthesized and tested for inhibition of human carbonic anhydrase I, II, IX and XII isoforms. The initial biochemical profiling revealed a significantly more potent inhibition of cancer-related, membrane-bound isoform hCA IX (reaching into submicromolar range), on top of potent inhibition of hCA XII that is another cancer target. The observed structure-activity relationships have been rationalized by molecular modeling. Comparative single-concentration profiling of the carbonic anhydrase inhibitors synthesized for antiproliferative effects against normal (ARPE-19) and cancer (PANC-1) cell lines under chemically induced hypoxia conditions revealed several candidate compounds selectively targeting cancer cells. More in-depth characterization of these leads revealed two structurally related compounds that showed promising selective cytotoxicity against pancreatic cancer (PANC-1) and melanoma (SK-MEL-2) cell lines. (C) 2018 Elsevier Masson SAS. All rights reserved.
机译:合成并测试含有含量含量的多样化的含1,2,4-二氧化唑的初级芳族磺酰胺,用于抑制人碳酸酐酶I,II,IX和XII同种型。初始生化分析显示出与癌症相关的癌症相关的膜结合同种型HCA IX(达到亚脉络范围)显着更有效的抑制作用,其具有另一种癌症靶标的HCA XII的有效抑制作用。观察到的结构 - 活性关系通过分子建模合理化。在化学诱导的缺氧条件下,用于对正常(ARPE-19)和癌症(PANC-1)细胞系的抗增殖作用合成的碳酸酐酶抑制剂的比较单浓度分析揭示了有选择性靶向癌细胞的几种候选化合物。更深入地表征这些引线揭示了两种结构相关的化合物,其表现出对胰腺癌(PANC-1)和黑素瘤(SK-MEL-2)细胞系的有前途的选择性细胞毒性。 (c)2018年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号